Lidocaine Hydrochloride And Hydrocortisone Acetate has 30 known drug interactions based on U.S. FDA drug labeling data. 30 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Acetaminophen, Acetazolamide, Articaine. Patients taking Lidocaine Hydrochloride And Hydrocortisone Acetate should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 30
- Major
- 30
Major (30)
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Acetaminophen— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to acetaminophen.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Acetazolamide— Increased risk of methemoglobinemia when lidocaine is used concurrently with these antibiotic oxidizing agents.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Articaine— Increased risk of methemoglobinemia when local anesthetics are concurrently used.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Benzocaine— Increased risk of methemoglobinemia when local anesthetics are concurrently used.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Bupivacaine— Increased risk of methemoglobinemia when local anesthetics are concurrently used.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Chloroquine— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to antimalarials.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Cyclophosphamide— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to antineoplastic agents.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Dapsone— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to antibiotics.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Flutamide— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to antineoplastic agents.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Hydroxyurea— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to antineoplastic agents.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Ifosfamide— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to antineoplastic agents.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Mepivacaine— Increased risk of methemoglobinemia when local anesthetics are concurrently used.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Metoclopramide— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to metoclopramide.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Nitric Oxide— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to nitrates/nitrites.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Nitrofurantoin— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to antibiotics.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Nitroglycerin— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to nitrates/nitrites.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Nitroprusside— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to nitrates/nitrites.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Nitrous Oxide— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to nitrates/nitrites.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Para-Aminosalicylic Acid— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to antibiotics.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Phenobarbital— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to anticonvulsants.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Phenytoin— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to anticonvulsants.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Prilocaine— Increased risk of methemoglobinemia when local anesthetics are concurrently used.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Primaquine— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to antimalarials.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Procaine— Increased risk of methemoglobinemia when local anesthetics are concurrently used.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Quinine— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to quinine.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Rasburicase— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to antineoplastic agents.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Ropivacaine— Increased risk of methemoglobinemia when local anesthetics are concurrently used.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Sulfasalazine— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to sulfa drugs.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Tetracaine— Increased risk of methemoglobinemia when local anesthetics are concurrently used.
- Lidocaine Hydrochloride And Hydrocortisone Acetate + Valproate Sodium— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to anticonvulsants.